Recovery from rhabdomyolysis after allogeneic BMT: report of a case with speculation on causation.
A case of fulminant rhabdomyolysis occurring 4 months after allogeneic BMT for CML is reported. The patient developed rhabdomyolysis following the empiric institution of antibacterial and anti-tuberculous medication. His inpatient course was complicated by the development of acute anuric renal failure and a severe myopathy. With aggressive supportive care, both of these complications resolved, making this patient the only reported survivor of rhabdomyolysis occurring after BMT.
Jackson
S R
SR
Leukemia/Bone Marrow Transplantation Program of British Columbia, Vancouver Hospital, Canada.
Barnett
M J
MJ
Keller
O
O
Nantel
S H
SH
Phillips
G L
GL
D016026:Bone Marrow Transplantation; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000503:physiopathology; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents